Citation Impact
Citing Papers
Prognostic Factors of Disease-Free Survival after Thyroidectomy in 170 Young Patients with a RET Germline Mutation: A Multicenter Study of the Groupe Français d'Etude des Tumeurs Endocrines
2010
Molecular Classification and Prognostication of Adrenocortical Tumors by Transcriptome Profiling
2009
Biochemically Silent Abdominal Paragangliomas in Patients with Mutations in the Succinate Dehydrogenase Subunit B Gene
2008
Tumor imaging by means of proteolytic activation of cell-penetrating peptides
2004 StandoutNobel
Case Detection, Diagnosis, and Treatment of Patients with Primary Aldosteronism: An Endocrine Society Clinical Practice Guideline
2008 Standout
Preoperative pharmacological management of phaeochromocytoma.
2006
Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
2009 Standout
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Apoptosis induction by combination of drugs or a conjugated molecule associating non-steroidal anti-inflammatory and nitric oxide donor effects in medullary thyroid cancer models: implication of the tumor suppressor p73
2015
Changing trends in the clinicopathological features and clinical outcomes of medullary thyroid carcinoma
2015
Genotype-phenotype correlation in multiple endocrine neoplasia type 2
2012
Multilineage Cells from Human Adipose Tissue: Implications for Cell-Based Therapies
2001 Standout
Current approaches to medullary thyroid carcinoma, sporadic and familial
2006
Hereditary hyperparathyroidism—a consensus report of the European Society of Endocrine Surgeons (ESES)
2015
Inherited pancreatic endocrine tumor syndromes: Advances in molecular pathogenesis, diagnosis, management, and controversies
2008
Pancreas Divisum Is Not a Cause of Pancreatitis by Itself But Acts as a Partner of Genetic Mutations
2011
The North American Neuroendocrine Tumor Society Consensus Guideline for the Diagnosis and Management of Neuroendocrine Tumors
2010
Comparison of free plasma metanephrines enzyme immunoassay with 131I-MIBG scan in diagnosis of pheochromocytoma
2008
Heterophilic antibodies causing falsely high serum calcitonin values
2006
The management of advanced thyroid cancer
2004
Pheochromocytomas and paragangliomas: assessment of malignant potential
2011
Molecular imaging in living subjects: seeing fundamental biological processes in a new light
2003 Standout
Everolimus for Advanced Pancreatic Neuroendocrine Tumors
2011 Standout
PTEN gene loss, but not mutation, in benign and malignant phaeochromocytomas
2006
Thyroid cancer
2016 Standout
Pheochromocytoma: recommendations for clinical practice from the First International Symposium
2007
Year of Diagnosis, Features at Presentation, and Risk of Recurrence in Patients with Pheochromocytoma or Secreting Paraganglioma
2005
High Frequency of Bone/Bone Marrow Involvement in Advanced Medullary Thyroid Cancer
2005
Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts
2007 Standout
Current Approaches to Primary Therapy for Papillary and Follicular Thyroid Cancer
2001 Standout
Does the RET variant G691S influence the features of sporadic medullary thyroid carcinoma?
2008
Endoscopic ultrasound in the localisation of pancreatic islet cell tumours
2005
Progression of medullary thyroid carcinoma: assessment with calcitonin and carcinoembryonic antigen doubling times
2008
Changes in risk factors and Tumor Node Metastasis stage of sporadic medullary thyroid carcinoma over 41 years, before and after the routine measurements of serum calcitonin
2010
Role of metastasectomy in the management of thyroid carcinoma: The NIH experience
2002
Volume-Based Trends in Thyroid Surgery
2010
Applicability of Intraoperative Parathyroid Hormone Assay During Thyroidectomy
2002
Intraoperative Pathologic Examination in the Era of Molecular Testing for Differentiated Thyroid Cancer
2012
Biological Relevance of Medullary Thyroid Microcarcinoma
2012
Noninsulinoma Pancreatogenous Hypoglycemia: A Novel Syndrome of Hyperinsulinemic Hypoglycemia in Adults Independent of Mutations in Kir6.2 and SUR1 Genes1
1999
Angiography-proven liver metastases explain low efficacy of lymph node dissections in medullary thyroid cancer patients
2004
The Thyroid Nodule
2004 Standout
Réintervention pour carcinome médullaire de la thyroïde : résultats à long terme
2001
Adrenal pheochromocytoma remains a frequently overlooked diagnosis
2000
Clinical and molecular aspects of adrenocortical tumourigenesis
2003
EMT and Dissemination Precede Pancreatic Tumor Formation
2012 Standout
Maximal safe dose of I-131 after failure of standard fixed dose therapy in patients with differentiated thyroid carcinoma
2008
Von Hippel‐Lindau gene alterations in sporadic benign and malignant pheochromocytomas
2003
Is routine supplementation therapy (calcium and vitamin D) useful after total thyroidectomy?
2002
CT and MR Imaging of the Adrenal Glands in ACTH-independent Cushing Syndrome
2004
Cushing's syndrome
2001
Postoperative PTH measurement facilitates day 1 discharge after total thyroidectomy
2008
Laparoscopic radiofrequency ablation of neuroendocrine liver metastases: a 10-year experience evaluating predictors of survival
2007
In vivo imaging of gene and cell therapies
2001
Molecular basis of the VHL hereditary cancer syndrome
2002 StandoutNobel
Adrenal lesions assessed in the era of laparoscopic adrenalectomy: a modern day series
2005
Recent developments in the therapy of phaeochromocytoma
2004
Cushing's syndrome
2015 Standout
Phaeochromocytoma
2005 Standout
Unilateral adrenal hyperplasia causing primary aldosteronism: limitations of I-131 norcholesterol scanning
2002
Point of controversy: perioperative care of patients undergoing pheochromocytoma removal–time for a reappraisal?
2011
Head and neck cancer
2008 Standout
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
2003 Standout
Understanding Catecholamine Metabolism as a Guide to the Biochemical Diagnosis of Pheochromocytoma
2001
Classification of Surgical Complications
2004 Standout
Perioperative management of pheochromocytoma
2002
Diagnostic Tests and Biomarkers for Pheochromocytoma and Extra-adrenal Paraganglioma: From Routine Laboratory Methods to Disease Stratification
2011
Non-Invasive Prenatal Diagnosis of Multiple Endocrine Neoplasia Type 2A Using COLD-PCR Combined with HRM Genotyping Analysis from Maternal Serum
2012
GSVA: gene set variation analysis for microarray and RNA-Seq data
2013 Standout
Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents
2017 Standout
Failure to Recognize Multiple Endocrine Neoplasia 2B: More Common Than We Think?
2007
Reoperative central compartment dissection for patients with recurrent/persistent papillary thyroid cancer: Efficacy, safety, and the association of the BRAF mutation
2012
Influence of experience on performance of individual surgeons in thyroid surgery: prospective cross sectional multicentre study
2012
Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors
2011 Standout
Presentation of a kindred with familial medullary thyroid carcinoma and Cys611Phe mutation of the RET proto-oncogene demonstrating low grade malignancy
2001
Benefit-Risk Balance of Reoperation for Persistent Medullary Thyroid Cancer
2012
Multiple Endocrine Neoplasia Type 2 and Familial Medullary Thyroid Carcinoma: An Update
2013
Prospects of Remission in Medullary Thyroid Carcinoma According to Basal Calcitonin Level
2005
Pancreatitis Risk in Primary Hyperparathyroidism: Relation to Mutations in the SPINK1 Trypsin Inhibitor (N34S) and the Cystic Fibrosis Gene
2008
Determination of calcitonin levels in C-cell disease: clinical interest and potential pitfalls
2008
Early prediction of postthyroidectomy hypocalcemia by one single iPTH measurement
2004
Sporadic Medullary Microcarcinoma of the Thyroid: A Retrospective Analysis of Eighty Cases
1998
External-beam radiation therapy in the treatment of differentiated thyroid cancer
1999
Role of Endoscopic Ultrasonography and Endoscopic Retrograde Cholangiopancreatography in the Clinical Assessment of Pancreatic Neoplasms
2016
Acute Pancreatitis
2016 Standout
Embolization in combination with radioiodine therapy for bone metastases from differentiated thyroid carcinoma
2000
Hemithyroidectomy: A Meta-Analysis of Postoperative Need for Hormone Replacement and Complications
2013
In vivo reprogramming of adult pancreatic exocrine cells to β-cells
2008 StandoutNature
Preoperative basal calcitonin and tumor stage correlate with postoperative calcitonin normalization in patients undergoing initial surgical management of medullary thyroid carcinoma
2011
Papillary Thyroid Carcinoma
1998
External Beam Radiation Therapy for Thyroid Cancer
2008
The effect of calcium channel blockers on outcome following the surgical treatment of phaeochromocytomas and paragangliomas
2005
Primary aldosteronism: renaissance of a syndrome
2007
Iodine-131 treatment and high-resolution CT: results in patients with lung metastases from differentiated thyroid carcinoma
2004
Thyroid Nodules: Clinical Importance, Assessment, and Treatment
2007
Prospective Study of Perioperative Factors Predicting Hypocalcemia After Thyroid and Parathyroid Surgery
2006
Evolution of Surgical Treatment of Primary Hyperparathyroidism in Patients With Multiple Endocrine Neoplasia Type 2A
2010
The Epidemiology of Pancreatitis and Pancreatic Cancer
2013 Standout
Advances in the management of hereditary medullary thyroid cancer
2004
Morbidity Following Central Compartment Reoperation for Recurrent or Persistent Thyroid Cancer
2004
Reference range of serum calcitonin levels in humans: influence of calcitonin assays, sex, age, and cigarette smoking
2007
Well-Differentiated Pancreatic Nonfunctioning Tumors/Carcinoma
2006
When should thyroidectomy be performed in familial medullary thyroid carcinoma gene carriers with non-cysteine RET mutations?
2003
Molecular Imaging
2001
Is laparoscopic adrenalectomy indicated for pheochromocytomas?
1996
RET proto-oncogene mutations affecting codon 790/791: A mild form of multiple endocrine neoplasia type 2A syndrome?
2002
Pheochromocytoma in multiple endocrine neoplasia type 2: a prospective study
2001
Long‐term follow‐up of patients with bone metastases from differentiated thyroid carcinoma – surgery or conventional therapy?
2002
High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn’s disease
2004 Standout
Metaiodobenzylguanidine (MIBG) scintigraphy and computed tomography (CT) in clinical practice. Primary and secondary evaluation for localization of phaeochromocytomas
2001
Surgical management of hyperparathyroidism in patients with multiple endocrine neoplasia type 2A
1996
Usefulness of 123I-MIBG Scintigraphy in the Evaluation of Patients with Known or Suspected Primary or Metastatic Pheochromocytoma or Paraganglioma: Results from a Prospective Multicenter Trial
2009
Parathyroid surgery in familial hyperparathyroid disorders*
2004
Clinical Experience Over 48 Years With Pheochromocytoma
1999
Complete surgical lymph node resection does not prevent authentic recurrences of medullary thyroid carcinoma
2001
Radiofrequency Ablation and Percutaneous Ethanol Injection Treatment for Recurrent Local and Distant Well-Differentiated Thyroid Carcinoma
2006
The roles of PTEN in development, physiology and tumorigenesis in mouse models: a tissue-by-tissue survey
2008 StandoutNobel
Plasma methoxytyramine: A novel biomarker of metastatic pheochromocytoma and paraganglioma in relation to established risk factors of tumour size, location and SDHB mutation status
2011
Prognostic factors for survival and for biochemical cure in medullary thyroid carcinoma: results in 899 patients
1998
Matching chelators to radiometals for radiopharmaceuticals
2013 Standout
Pamidronate improves the quality of life and induces clinical remission of bone metastases in patients with thyroid cancer
2001
Inducible and Constitutive β-Defensins Are Differentially Expressed in Crohn's Disease and Ulcerative Colitis
2003
Successful growth and characterization of mouse pancreatic ductal cells: functional properties of the Ki-RASG12V oncogene
2004
Effects of vascular endothelial growth factor on pancreatic duct cell replication and the insulin production of fetal islet-like cell clusters in vitro
1997
Clinical and biochemical features of sporadic and hereditary phaeochromocytomas: an analysis of 41 cases investigated in a single endocrine centre
2004
Targeting autophagy in cancer
2017 Standout
Total Thyroidectomy Plus Neck Dissection in Differentiated Papillary Thyroid Carcinoma Patients
2007 Standout
Caspase-3 Inhibitor Prevents Apoptosis of Human Islets Immediately After Isolation and Improves Islet Graft Function
2004
Adult stem cell plasticity
2002
Prevalence and natural history of adrenal incidentalomas
2003
The von Hippel–Lindau protein, HIF hydroxylation, and oxygen sensing
2005 StandoutNobel
Comparison of Two Preoperative Medical Management Strategies for Laparoscopic Resection of Pheochromocytoma
2010
Predictive DNA testing for multiple endocrine neoplasia 2: A therapeutic challenge of prophylactic thyroidectomy in very young children
1999
Follicular Thyroid Carcinoma in an Iodine-Replete Endemic Goiter Region
2009
Cushing's syndrome
2006 Standout
123I‐metaiodobenzylguanidine (MIBG) scintigraphy for the detection of adrenal and extra‐adrenal phaeochromocytomas: CT and MRI correlation
2008
Bone metastases from differentiated thyroid carcinoma
2008
Management and Treatment of Pheochromocytomas and Paragangliomas
2006
Very early detection of RET proto‐oncogene mutation is crucial for preventive thyroidectomy in multiple endocrine neoplasia type 2 children
2002
Computationally Designed Bispecific Antibodies using Negative State Repertoires
2016
Mortality associated with pheochromocytoma in a large Swedish cohort
2004
Differential Genetic Alterations in von Hippel-Lindau Syndrome-Associated and Sporadic Pheochromocytomas1
2000
Prophylactic thyroidectomy in multiple endocrine neoplasia: the impact of molecular mechanisms of RET proto-oncogene
2003
Discordant localization of 2-[18F]-fluoro-2-deoxy-D-glucose in 6-[18F]-fluorodopamine- and [123I]-metaiodobenzylguanidine-negative metastatic pheochromocytoma sites
2005
Hypercalcitoninemia in thyroid conditions other than medullary thyroid carcinoma: a comparative analysis of calcium and pentagastrin stimulation of serum calcitonin
2013
Familial Medullary Thyroid Carcinoma with Noncysteine RET Mutations: Phenotype-Genotype Relationship in a Large Series of Patients
2001
Tumours of familial origin in the head and neck
2006
Mutation analysis of the RET proto-oncogene and early thyroidectomy: results of a Portuguese cancer centre
2006
Adenovirus-mediated catalase gene transfer reduces oxidant stress in human, porcine and rat pancreatic islets
1998
Multiple Endocrine Neoplasia Type 2
2003
Diagnosis and Treatment of Primary Aldosteronism
2011
Early Onset of Medullary Thyroid Carcinoma in a Kindred with Multiple Endocrine Neoplasia Type IIA Associated with Cutaneous Lichen Amyloidosis
2002
Outcomes analysis in patients undergoing laparoscopic adrenalectomy for hormonally active adrenal tumors
2001
Bone Metastases from Thyroid Carcinoma: Clinical Characteristics and Prognostic Variables in One Hundred Forty-Six Patients
2000
Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma
2015 Standout
Prevalence and Clinical Spectrum of Nonsecretory Medullary Thyroid Carcinoma in a Series of 839 Patients with Sporadic Medullary Thyroid Carcinoma
2012
Papillary Thyroid Carcinomas with Lung Metastases
2004
Normal Perioperative Serum Calcitonin Levels in Patients with Advanced Medullary Thyroid Carcinoma: Case Report and Review of the Literature
2008
Medullary Thyroid Cancer: Management Guidelines of the American Thyroid Association
2009 Standout
Current Controversies in the Management of Pediatric Patients with Well-Differentiated Nonmedullary Thyroid Cancer: A Review
2002
The Benefits and Risks of I-131 Therapy in Patients with Well-Differentiated Thyroid Cancer
2009
The Role of Radiotherapy in the Management of Elevated Calcitonin After Surgery for Medullary Thyroid Cancer
2001
Lymph node metastases and elevated postoperative calcitonin: Predictors of poor survival in medullary thyroid carcinoma
2015
Lymph node dissection and medullary thyroid carcinoma
2002
In vitro cultivation of human islets from expanded ductal tissue
2000
Calcitonin measurement in aspiration needle washout fluids has higher sensitivity than cytology in detecting medullary thyroid cancer: a retrospective multicentre study
2013
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
Is basal ultrasensitive measurement of calcitonin capable of substituting for the pentagastrin‐stimulation test?
2012
RET as a Diagnostic and Therapeutic Target in Sporadic and Hereditary Endocrine Tumors
2006
Preoperative risk assessment in elective general surgery
1996
Neural Monitored Revision Thyroid Cancer Surgery: Surgical Safety and Thyroglobulin Response
2013
Immunoscintigraphy with positron emission tomography: gallium-68 chelate imaging of breast cancer pretargeted with bispecific anti-MUC1/anti-Ga chelate antibodies.
2001
Management of Simple Nodular Goiter: Current Status and Future Perspectives
2003
Preoperative Management of the Pheochromocytoma Patient
2007
American Association Of Clinical Endocrinologists, Associazione Medici Endocrinologi, And European Thyroid Association Medical Guidelines For Clinical Practice For The Diagnosis And Management Of Thyroid Nodules
2010 Standout
Vascular Endothelial Growth Factor: Basic Science and Clinical Progress
2004 Standout
Long‐term Follow‐up after Adrenalectomy for Primary Aldosteronism
2005
Importance ofin situpreservation of parathyroid glands during total thyroidectomy
2015
Diagnosis of Pheochromocytoma
1988
Genotype‐Phenotype Based Surgical Concept of Hereditary Medullary Thyroid Carcinoma
2007
Adrenocortical carcinoma: a clinician's update
2011
Sensitivity and Prognostic Value of Positron Emission Tomography with F-18-Fluorodeoxyglucose and Sensitivity of Immunoscintigraphy in Patients with Medullary Thyroid Carcinoma Treated with Anticarcinoembryonic Antigen-Targeted Radioimmunotherapy
2007
Primary Aldosteronism: Factors Associated with Normalization of Blood Pressure after Surgery
2001
New Strategies for Fluorescent Probe Design in Medical Diagnostic Imaging
2009 Standout
Complications of Laparoscopic Adrenalectomy: Results of 169 Consecutive Procedures
2000
Reference Intervals for Serum Calcitonin in Men, Women, and Children
2004
Familial Medullary Thyroid Carcinoma: Clinical Variability and Low Aggressiveness Associated withRETMutation at Codon 804
2002
Predictive Value of Serum Calcitonin Levels for Preoperative Diagnosis of Medullary Thyroid Carcinoma in a Cohort of 5817 Consecutive Patients with Thyroid Nodules
2006
Risk and Penetrance of Primary Hyperparathyroidism in Multiple Endocrine Neoplasia Type 2A Families with Mutations at Codon 634 of the RET Proto-Oncogene
1998
Functional mapping of disease susceptibility loci using cell biology
2006 StandoutNobel
Value of the Cervical Compartments in the Surgical Treatment of Papillary Thyroid Carcinoma
2004
Evidence for the Role of Perioperative PTH Measurement after Total Thyroidectomy as a Predictor of Hypocalcemia
2008
The Diagnosis and Medical Management of Advanced Neuroendocrine Tumors
2004
Oxidative Stress and Stress-Activated Signaling Pathways: A Unifying Hypothesis of Type 2 Diabetes
2002 Standout
Five‐year Follow‐up of a Randomized Clinical Trial of Total Thyroidectomy versus Dunhill Operation versus Bilateral Subtotal Thyroidectomy for Multinodular Nontoxic Goiter
2010
SUCCESSFUL OUTCOMES IN PHEOCHROMOCYTOMA SURGERY IN THE MODERN ERA
1999
Long-term follow-up and cost benefit of adrenalectomy in patients with primary hyperaldosteronism
2002
Pheochromocytoma
2002
Role of prophylactic thyroidectomy in RET 790 familial medullary thyroid carcinoma
2011
Abnormal carcinoembryonic antigen levels and medullary thyroid cancer progression: a multivariate analysis.
2007
Review of Multiple Endocrine Neoplasia Type 2A in Children: Therapeutic Results of Early Thyroidectomy and Prognostic Value of Codon Analysis
2003
Radiometal-Labeled Agents (Non-Technetium) for Diagnostic Imaging
1999
Characterization of Endocrine Progenitor Cells and Critical Factors for Their Differentiation in Human Adult Pancreatic Cell Culture
2003
Adrenal cortical carcinoma
2001
Clinical Presentations, Biochemical Phenotypes, and Genotype-Phenotype Correlations in Patients withSuccinate Dehydrogenase Subunit B-Associated Pheochromocytomas and Paragangliomas
2007
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline
2016 Standout
The evolving role of (131)I for the treatment of differentiated thyroid carcinoma.
2005
Lineage tracing and characterization of insulin-secreting cells generated from adult pancreatic acinar cells
2005
Survival and Therapeutic Modalities in Patients with Bone Metastases of Differentiated Thyroid Carcinomas
2001
Multiple Endocrine Neoplasia Type 2A in a Kindred With C634Y Mutation
2005
Follicular Adenoma and Carcinoma of the Thyroid Gland
2011
Approach to the Thyroid Cancer Patient with Bone Metastases
2011
Intraoperative Parathyroid Hormone Assay
2011
A Current Review of the Etiology, Diagnosis, and Treatment of Pediatric Pheochromocytoma and Paraganglioma
2010
Selective Use of Adrenal Venous Sampling in the Lateralization of Aldosterone‐producing Adenomas
2006
Vascular Remodeling and Duration of Hypertension Predict Outcome of Adrenalectomy in Primary Aldosteronism Patients
2008
Outcome of 309 patients with metastatic differentiated thyroid carcinoma treated with radioiodine
1994
Advances in Copper Complexes as Anticancer Agents
2013 Standout
Biomarker-Based Risk Stratification for Previously Untreated Medullary Thyroid Cancer
2010
Acute Pancreatitis in Primary Hyperparathyroidism: A Population-Based Study
2009
Laparoscopic bilateral adrenalectomy for persistent Cushing's disease after transsphenoidal surgery
1998
Guidelines for the management of thyroid cancer
2014 Standout
Adrenocortical Carcinoma
2013
Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro.
1990 Standout
Prognostic Significance of the Number of Metastatic Lymph Nodes to Stratify the Risk of Recurrence
2013
Current Update on Medullary Thyroid Carcinoma
2013
Risk Factors for Nodal Metastasis and Recurrence Among Patients with Papillary Thyroid Microcarcinoma: Differences in Clinical Relevance Between Nonincidental and Incidental Tumors
2009
The Clinically Inapparent Adrenal Mass: Update in Diagnosis and Management
2004
Rapid Cortisol Assay during Adrenal Vein Sampling in Patients with Primary Aldosteronism
2007
Mutations of β-Catenin in Adrenocortical Tumors: Activation of the Wnt Signaling Pathway Is a Frequent Event in both Benign and Malignant Adrenocortical Tumors
2005
Multiple Endocrine Neoplasia 2a Presenting with Pheochromocytoma and Pituitary Macroadenoma
2011
Systematic Review: Diagnostic Procedures to Differentiate Unilateral From Bilateral Adrenal Abnormality in Primary Aldosteronism
2009
Role ofVHLGene Mutation in Human Cancer
2004 StandoutNobel
Minimally invasive follicular thyroid cancer (MIFTC)—a consensus report of the European Society of Endocrine Surgeons (ESES)
2013
Reconfigurable asymmetric protein assemblies through implicit negative design
2022 StandoutScienceNobel
Thyroid carcinoma
2003 Standout
Improved Contemporary Surgical Management of Insulinomas
2008
The role of epinephrine, norepinephrine, and dopamine in blood pressure disturbances in patients with pheochromocytoma
1992
Inorganic Nanoparticles for MRI Contrast Agents
2009 Standout
Pheochromocytoma and Paraganglioma: An Endocrine Society Clinical Practice Guideline
2014 Standout
Imaging of advanced neuroendocrine tumors with (18)F-FDOPA PET.
2004
Primary aldosteronism: diagnostic and treatment strategies
2006
Resistant Hypertension: Diagnosis, Evaluation, and Treatment
2008 Standout
Works of C Proye being referenced
Safety of the posterior approach in adrenal surgery: experience in 105 cases.
1993
Efficacy of iodine-131 6β-methyl-iodo-19-norcholesterol scintigraphy and computed tomography in patients with primary aldosteronism
1999
Long-term results of less than total parathyroidectomy for hyperparathyroidism in multiple endocrine neoplasia type 1
2002
Preoperative Calcitonin Levels Are Predictive of Tumor Size and Postoperative Calcitonin Normalization in Medullary Thyroid Carcinoma
2000
Early or prophylactic thyroidectomy in MEN 2/FMTC gene carriers: results in 71 thyroidectomized patients. The French Calcitonin Tumours Study Group (GETC)
1999
TUMOUR SIZE: THE ONLY PREDICTIVE FACTOR FOR 131I MIBG UPTAKE IN PHAEOCHROMOCYTOMA AND PARAGANGLIOMA
1999
Questionability of the benefits of routine laparotomy as the surgical approach for pheochromocytomas and abdominal paragangliomas
1996
Prognostic value ofRET proto-oncogene point mutations in malignant and benign, sporadic phaeochromocytomas
1998
The value of lymph node dissection in hereditary medullary thyroid carcinoma: a retrospective, European, multicentre study
1995
Clinical evaluation of a new sensitive calcitonin assay: study of specificity
2001
Weiss System Revisited
2002
Effectiveness and limits of preoperative imaging studies for the localisation of pheochromocytomas and paragangliomas: a review of 282 cases
2002
Les gastrinomes dans les néoplasies endocriniennes multiples de type 1. Une étude de cohorte de 127 cas du groupe des tumeurs endocrines (GTE)
2004
CURRENT PERSPECTIVES IN THE SURGERY OF MULTIPLE ENDOCRINE NEOPLASIAS
1999
Essential hypertension: First reason for persistent hypertension after unilateral adrenalectomy for primary aldosteronism?
1998
Primary hyperparathyroidism in multiple endocrine neoplasia type 2A
1995
Noninvasive imaging of insulinomas and gastrinomas with endoscopic ultrasonography and somatostatin receptor scintigraphy
1998
PANCREATITIS AND PRIMARY HYPERPARATHYROIDISM: FORTY CASES
1998
Prognostic factors in patients with Zollinger-Ellison syndrome and multiple endocrine neoplasia type 1
1999
Proliferative index in phaeochromocytomas: does it predict the occurrence of metastases?
2000
Les insulinomes dans les néoplasies endocriniennes multiples de type 1 (NEM1). À propos d'une série de 44 cas du groupe d'étude des néoplasies endocriniennes multiples (GENEM)
2000
Epidemiology Data on 108 MEN 1 Patients From the GTE With Isolated Nonfunctioning Tumors of the Pancreas
2006
“The” pheochromocytoma: A benign, intra‐adrenal, hypertensive, sporadic unilateral tumor. Does it exist?
1994
Why Do Frozen Sections Have Limited Value in Encapsulated or Minimally Invasive Follicular Carcinoma of the Thyroid?
2001
Experience gained from operation of 103 adrenal incidentalomas
1998
Comparison of somatostatin analogue and metaiodobenzylguanidine scintigraphy for the detection of carcinoid tumours
1996
Culture of human islets before transplantation in serum-free media
1997
Thyroid Carcinomas Involving Follicular and Parafollicular C Cells: Seventeen Cases with Characterization of RET Oncogenic Activation
2004
Adrenocortical carcinoma in surgically treated patients: a retrospective study on 156 cases by the French Association of Endocrine Surgery.
1992
Preoperative imaging versus intraoperative localization of tumors in adult surgical patients with hyperinsulinemia: A multicenter study of 338 patients
1988
Surgery for benign insulinoma: An international review
1990
Radionuclide scanning in parathyroid diseases
1998
Is Surgery Beneficial for MEN1 Patients with Small (≤2 cm), Nonfunctioning Pancreaticoduodenal Endocrine Tumor? An Analysis of 65 Patients from the GTE
2006
Exclusive use of calcium channel blockers in preoperative and intraoperative control of pheochromocytomas: hemodynamics and free catecholamine assays in ten consecutive patients.
1989
Radioimmunodetection of medullary thyroid carcinoma using indium-111 bivalent hapten and anti-CEA x anti-DTPA-indium bispecific antibody.
1998
Adrenocortical carcinomas: surgical trends and results of a 253‐patient series from the French Association of Endocrine Surgeons study group
2001
Adult human cytokeratin 19-positive cells reexpress insulin promoter factor 1 in vitro: further evidence for pluripotent pancreatic stem cells in humans.
2000
[Dopamine-secreting pheochromocytoma. An unrecognized entity?].
1984
Ductal Cyst Formation in Collagen-Embedded Adult Human Islet Preparations: A Means to the Reproduction of Nesidioblastosis In Vitro
1996
Indications for adrenalectomy in the laparoscopic era.
2001
Human Pancreatic Ductal Cells: Large-Scale Isolation and Expansion
2001
Dopamine-secreting pheochromocytoma: an unrecognized entity? Classification of pheochromocytomas according to their type of secretion.
1986
[Recurrence of cervical lymph node involvement in surgically treated thyroid cancer. Uselessness of routine cervical lymph node excision (medullary carcinoma excluded)].
1992
[Pheochromocytoma. Experience of 60 operations].
1989
[Loco-regional persistence and recurrences of operated differentiated thyroid cancers. 22 cases on 589 treated patients from 1964 to 1990, follow-up from 5 to 31 years].
1997
Primary Hyperparathyroidism in Multiple Endocrine Neoplasia Type IIa: Retrospective French Multicentric Study
1996
Future of Thyroid Surgery and Training Surgeons to Meet the Expectations of 2000 and Beyond
2000
Hypocalcemia following Thyroid Surgery: Incidence and Prediction of Outcome
1998
Intraoperative Gastrin Measurements during Surgical Management of Patients with Gastrinomas: Experience with 20 Cases
1998
[Mortality in a general surgery department of a University Hospital Center. A study during 1985: 1409 surgically treated cases, 45 postoperative deaths].
1988
Simple dithizone-stained multilayer test for selection of density gradient before human islet mass purification.
1994
Current Concepts in Functioning Endocrine Tumors of the Pancreas
2004
[Decision-making for lymph node excision in surgery of thyroid cancer. Extemporaneous examination of the external supraclavicular lymph nodes].
1990
Hyperparathyroidism in multiple endocrine neoplasia type I: Surgical trends and results of a 256‐patient series from groupe d’Etude des Néoplasies endocriniennes multiples study group
2001
Chromogranin A assay and (131)I-MIBG scintigraphy for diagnosis and follow-up of pheochromocytoma.
2001
Is it still worthwhile to treat bone metastases from differentiated thyroid carcinoma with radioactive iodine?
1992